Sunday, February 3, 2008
No Reduction In Risk Of Heart Attack When Ezetimibe ...
On January 14, 2008, Merck/Schering Plough Pharmaceuticals issued a Press Release reporting preliminary results from the Effect of Combination Ezetimibe and High-Dose Simvastatin vs. Simvastatin Alone on the Atherosclerotic Process in Patients with Heterozygous Familial Hypercholesterolemia (ENHANCE)
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment